| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |